- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.05. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 24.04. | iTonic Holdings (ITOC) Stock Surges Over 66% After Hours: Why Is It Moving? | 1 | Benzinga.com | ||
| 23.04. | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | 246 | GlobeNewswire (Europe) | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 23.04. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 24.03. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 26.01. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| ITONIC Aktie jetzt für 0€ handeln | |||||
| 13.01. | Pheton Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.01. | Pheton Holdings to change name to iTonic, ticker to ITOC | 2 | Seeking Alpha | ||
| 13.01. | Pheton Holdings Ltd. Announces Corporate Name Change and Stock Ticker Symbol Change | 1.403 | GlobeNewswire (Europe) | BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 05.12.25 | Pheton Holdings Ltd. Announces Closing of Share Acquisition with iTonic | 478 | GlobeNewswire (Europe) | Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) ("Pheton" or the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen | |
| 23.10.25 | Pheton Holdings Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 771 | GlobeNewswire (Europe) | Beijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and... ► Artikel lesen | |
| 01.08.25 | Pheton Holdings Ltd. Issues Statements Addressing Recent Market Activity and Misleading Rumors | 728 | GlobeNewswire (Europe) | BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company," "we," "our" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,498 | +1,22 % | HEALWELL AI informiert über Neuigkeiten aus dem Unternehmen: Annahme der Forschungsergebnisse aus provinzübergreifendem KI-Pilotprojekt beim AMIA-Symposium und Stärkung der Bilanz durch SpaceX-Beteiligung | - HEALWELL hat erfolgreich ein Pilotprojekt zur Bewertung seiner auf DARWEN basierenden KI-Lösungen SMART Summary und SMART Search in mehreren kanadischen Provinzen
abgeschlossen. Das... ► Artikel lesen | |
| INSULET | 120,90 | -0,53 % | Insulet has a new chief R&D officer | ||
| LIFEWARD | 7,060 | +3,82 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| SENSEONICS | 5,450 | -2,68 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| IMUNON | 1,620 | 0,00 % | Imunon, Inc.: IMUNON to Present at the Life Sciences Investor Forum on June 25th | ||
| LANTHEUS | 90,60 | -2,58 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,600 | +3,87 % | Inspire Medical data highlights cardiovascular outcomes with neuromod for sleep apnea | ||
| INSPIREMD | 0,610 | -3,17 % | InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR | ||
| GT BIOPHARMA | 0,533 | +3,77 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,550 | 0,00 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| MYOMO | 1,092 | -1,44 % | Myomo übertrifft Q1-Prognosen, Aktie gibt dennoch nach | ||
| INTELLIGENT BIO SOLUTIONS | 2,350 | +2,62 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,230 | -9,27 % | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| GLUCOTRACK | 0,384 | +4,21 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,565 | +4,61 % | Lexaria Bioscience Corp.: GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand | More People Than Ever Taking GLP-1 Drugs for Weight LossGrowing List of Diseases Now Indicated as Treatable With GLP-1 Drugs KELOWNA, BC / ACCESS Newswire / June 17, 2026 / Lexaria Bioscience Corp.... ► Artikel lesen |
ITONIC HOLDINGS LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,325 Euro und damit +3,87 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ITONIC HOLDINGS LTD finden Sie auf Wallstreet Online.